Interview with Vancouver’s The Tyee on antibody-based therapy for COVID-19

Vancouver biotech company AbCellera is developing antibodies to treat COVID-19. In the six-minute video below from The Tyee, Ralph Pantophlet is interviewed alongside Véronique Lecault, COO of AbCellera. They explain what antibody treatment is and endeavors to apply it to COVID-19. The video also explains how advances in technology are helping to find and isolate the right antibodies.


Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies

Our latest research contribution to identifying potential hurdles to the elicitation of glycan-specific HIV-neutralizing antibodies has just been published with @SpringerNature in @Scientific Reports! Read here: [article]

Meet SFU undergraduate researcher Yiqiu Yang

Yiqiu, one of our talented undergrad research interns and a 3rd year student in the Department of Molecular Biology and Biochemistry, talks to SFU-SURJ (Science Undergraduate Research Journal) about the research that she has contributed to in the lab over the last several months.


Quiana receives USRA and admittance to the graduate program in Health Sciences!

Congratulations to Quiana Ang! Quiana has been awarded her second Undergraduate Student Research Award (USRA), which will enable her to continue her undergraduate research in the Pantophlet Lab over the summer, and has been accepted as a Master’s student in the Faculty of Health Sciences for Fall 2020!

Congratulations to Ed Bigornia!

Congratulations to Edarlin Bigornia, most recent undergraduate member of the Pantophlet Lab, who convocated this past week!


Join the Pantophlet Lab @ SFU!

The Pantophlet Lab is seeking an experienced Research Assistant to support ongoing NIH- and CIHR-funded research related to HIV and flu vaccine development. Candidates will be interviewed on a rolling basis until the position is filled.

For more information, visit our Opportunities page.

Government of Canada investing in Canadian researchers to help them make world-class discoveries

Official announcement of funding through the Canada Foundation for Innovation’s John R. Evans Leaders Fund (JELF). The Hon. Kirsty Duncan, Minister of Science and Sport, made the announcement today while visiting SFU’s Burnaby Campus. Dr. Ralph Pantophlet is one of three SFU lead researchers to receive JELF funding. The Pantophlet lab will acquire a new-generation flow cytometry system, enabling high-resolution analyses of immune responses and precise recovery of immune cells, thus stimulating new vaccine and cure strategies.
[Government of Canada announcement] [PDF]
[Simon Fraser News announcement] [PDF]

SFU undergraduate researcher: Quratulain Qureshi

Quratulain, an undergrad research intern in the Pantophlet Lab, talks to SFU-SURJ (Science Undergraduate Research Journal) in a short blog post about her work in the lab these past few months. In addition, she discusses how she got into research and her career goals and aspirations.

[article] [PDF]

Trianni, Inc. and Simon Fraser University announce licensing agreement for the Trianni Mouse™

SFU has entered into a license agreement for the Trianni Mouse™, a best-in-class human monoclonal antibody discovery platform. The platform incorporates a complete human antibody repertoire and will support HIV, influenza and other vaccine research and development efforts in the Pantophlet Lab.


Adapting to change: The challenge of HIV vaccine development

Science Communicator Emerson Gaglardi blogs on Science Borealis about vaccines, the challenges of HIV vaccine development and his interview with Dr. Pantophlet about exciting research in the Pantophlet Lab in their efforts to develop an effective HIV vaccine formulation.

[article] [PDF]